首页> 外文期刊>Journal of clinical sleep medicine: JCSM : official publication of the American Academy of Sleep Medicine >Syndrome of inappropriate antidiuretic hormone secretion induced by suvorexant: a case report
【24h】

Syndrome of inappropriate antidiuretic hormone secretion induced by suvorexant: a case report

机译:Suvorexant诱导的不适当抗性激素分泌综合征:案例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Syndrome of inappropriate antidiuretic hormone release (SIADH) can sometimes be caused by an adverse effect of certain psychotropic drugs. However, suvorexant has never been reported to cause SIADH. A 77-year-old man with type 2 diabetes was admitted to the Jichi Medical University Hospital for the treatment of major depression. During the treatment, he was prescribed suvorexant for insomnia. Twelve days after the initiation of suvorexant, he developed hyponatremia, which met the diagnostic criteria of SIADH. We suspected the hyponatremia to be an adverse drug effect of suvorexant because no other cause for SIADH was detected. Accordingly, suvorexant was discontinued 15 days after the onset of SIADH, and hyponatremia improved in 6 days. Although suvorexant has fewer adverse drug reactions and is considered relatively safe, clinicians should be aware of the possibility of SIADH induced by suvorexant.
机译:抗利尿激素释放不当综合征(SIADH)有时可由某些精神药物的不良反应引起。然而,suvorexant从未被报道导致SIADH。一名患有2型糖尿病的77岁男子因重度抑郁症入院治疗。在治疗过程中,他被开了苏伏雷克松治疗失眠。在开始服用舒伏雷克松12天后,他出现低钠血症,符合SIADH的诊断标准。我们怀疑低钠血症是suvorexant的不良药物效应,因为没有检测到SIADH的其他原因。因此,suvorexant在SIADH发病15天后停用,低钠血症在6天内得到改善。虽然舒沃雷辛的不良反应较少,且被认为相对安全,但临床医生应意识到舒沃雷辛诱发SIADH的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号